- Atorvastatin and Myocardial Extracellular Volume Expansion During Anthracycline-Based Chemotherapy
JACC CardioOncology · 2025
- Inactivation of Notch1-TGF-β-Smads Signaling Pathway by Atorvastatin Improves Cardiac Function and Hemodynamic Performance in Acute Myocardial Infarction Rats
Journal of Vascular Research · 2025
- Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolism
Frontiers in Oncology · 2025
- Effects of Preloading with High Dose of Atorvastatin Prior to Percutaneous Coronary Intervention: A Single Center Randomized Controlled Trial
BioScientific Review · 2025
- Distal Landing Zone-Related Complications of Conventional Endovascular Aneurysm Repair (EVAR) in the Long Term: A Comprehensive Systematic Review
Cureus · 2025
- Successful use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Hypertriglyceridemia-induced Acute Pancreatitis: A Case Report
Current Cardiology Reviews · 2025
- Adherence to perindopril/amlodipine/atorvastatin combination according to the administration strategy
European Heart Journal - Quality of Care and Clinical Outcomes · 2025
- LDL-cholesterol lowering agents (statins and PCSK9 inhibitors) and the risk of intracerebral hemorrhage: A network meta-analysis
Journal of Stroke and Cerebrovascular Diseases · 2025
- Comparison of Apixaban with Warfarin for the Prevention of Subclinical Cerebral Infarction after Direct Current Cardioversion in Patients with Atrial Fibrillation
Chonnam Medical Journal · 2025
- Effects of Rivaroxaban on Prognosis in Patients with Acute Myocardial Infarction and Preexisting Atrial Fibrillation
Cardiovascular Innovations and Applications · 2025
- Canagliflozin ameliorates ferritinophagy in HFpEF rats
Journal of Geriatric Cardiology · 2025
- Lipoprotein(a) and Atrial Fibrillation: Mechanistic Insights and Therapeutic Approaches
International Journal of Medical Sciences · 2024
- Assessment of dyslipidemia management in Turkey using a Delphi panel
Scientific Reports · 2024
- ANGPTL3 overcomes sorafenib resistance via suppression of SNAI1 and CPT1A in liver cancer
Translational Oncology · 2024
- An up-to-date review of emerging biologic therapies for hypercholesterolemia
Expert Opinion on Biological Therapy · 2024
- A comparative analysis of the safety profiles between inclisiran and other PCSK9 inhibitors from real-world evidence – what have we learned recently?
Expert Opinion on Drug Safety · 2024
- Efficacy and safety of edoxaban in patients with cardioembolic stroke
INTERNATIONAL NEUROLOGICAL JOURNAL · 2024
- Potential interactions between direct oral anticoagulants and atorvastatin/simvastatin: a cohort and case-crossover study
British Journal of General Practice · 2024
- Lipid-lowering therapies for aortic stenosis: a drug-target Mendelian randomization study
European Heart Journal - Cardiovascular Pharmacotherapy · 2024
- Statin-treated RBC dynamics in a microfluidic porous-like network
Microvascular Research · 2024
- Efficacy and safety of direct oral anticoagulants in patients with implanted inferior vena cava filters: a systematic review and meta-analysis
Ambulatornaya khirurgiya = Ambulatory Surgery (Russia) · 2024
- Baseline Characteristics of Participants in STAREE: A Randomized Trial for Primary Prevention of Cardiovascular Disease Events and Prolongation of Disability‐Free Survival in Older People
Journal of the American Heart Association · 2024
- Designing and evaluating ECG interpretation software for undergraduate nursing students in Iran: a non-equivalent control group pretest-posttest design
BMC Nursing · 2024
- Perioperative Tranexamic Acid Should Be Considered for Total Joint Arthroplasty Patients Receiving Apixaban for Thromboprophylaxis
Arthroplasty Today · 2024
- Aerobic exercise alleviates statin-induced PCSK9 upregulation by increasing epoxyeicosatrienoic acid levels through the FoxO3a–Sirt6 axis
Journal of sport and health science/Journal of Sport and Health Science · 2024
- From the INVICTUS Trial to Current Considerations: It’s Not Time to Retire Vitamin K Inhibitors Yet!
Pharmaceuticals · 2024
- Efficacy and Safety of Rivaroxaban, Apixaban, and Edoxaban for Nonvalvular Atrial Fibrillation Based on Blood Coagulation Activity and Drug Plasma Concentration: SETtsu and North Osaka Multicenter Direct Oral AntiCoagulant (SET DOAC) Registry
Pharmaceuticals · 2024
- Impact of High-Intensity Statin on Atrial Fibrillation after Off-Pump Coronary Artery Bypass
The Thoracic and Cardiovascular Surgeon · 2024
- Physical‐Matched Nanoplatelets Boost Heterogeneous Thrombi Targeting Through Self‐Adaptive Deformation for Thrombolysis and Endothelial Repairing
Small · 2024
- Anti-inflammatory effects of proprotein convertase subtilisin/kexin 9 inhibitor therapy in the early phase of acute myocardial infarction
Heart and Vessels · 2024
- The effect of edoxaban on apoptosis in an abdominal aortic aneurysm model in rats
Turkish Journal of Thoracic and Cardiovascular Surgery · 2024
- Statin suppresses the development of excessive intimal proliferation in a Kawasaki disease mouse model
Physiological Reports · 2024
- Evaluation of changes in the global longitudinal strain for left ventricular function before and after eight weeks of taking high dose of atorvastatin in patients with coronary slow flow phenomenon
BMC Cardiovascular Disorders · 2024
- Should a physician use the Beers criteria when prescribing direct oral anticoagulants to elderly patients?
Rational Pharmacotherapy in Cardiology · 2024
- PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention
Lipids in Health and Disease · 2024
- Comparison of Efficacy of Atorvastatin and Rosuvastatin in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
Cureus · 2024
- The Effects of Pretreatment with Atorvastatin, Fenofibrate, or Both Drugs in a Mouse Model of Acute Lipemia Induced by the General Lipase Inhibitor Poloxamer 407
Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · 2024
- Early administration of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis
BMC Cardiovascular Disorders · 2024
- Proprotein convertase subtilisin/kexin type 9 as a drug target for abdominal aortic aneurysm
Current Opinion in Lipidology · 2024
- Clinical Outcomes of Aspirin and Clopidogrel among Patients with Chronic Obstructive Lung Disease: Insights from a Meta-Analysis
Journal of Clinical Medicine · 2024
- Effect of adding<scp>PCSK9</scp>inhibitors to lipid‐lowering interventions on arterial stiffness: A systematic review and meta‐analysis
European Journal of Clinical Investigation · 2024
- Efficacy and safety of proprotein convertase subtilisin kexin type (PCSK9) inhibitors in patients with acute coronary syndrome: A systematic review and meta-analysis
Medicine · 2024
- New insights into the therapeutic options to lower lipoprotein(a)
European Journal of Clinical Investigation · 2024
- Management of dyslipidemia in coronary artery disease: the present and the future
Coronary Artery Disease · 2024
- Efficacy and Safety of Combination Therapy with Low-Dose Rivaroxaban in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Journal of Clinical Medicine · 2024
- Proprotein convertase subtilisin/kexin type 9-inhibition across different patient populations
Current Opinion in Lipidology · 2024
- The Lipid–Platelet Interplay: Unraveling the Effects of PCSK9 Inhibition on Platelet Reactivity
Thrombosis and Haemostasis · 2024
- Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy
Atherosclerosis · 2024
- Evolocumab-Based LDL-C Management in High and Very High Cardiovascular Risk Patients in German Clinical Practice: The HEYMANS Study
Advances in Therapy · 2024
- A case report of postcardioversion device-related thrombus in a patient with left atrial appendage occlusion device on apixaban
Annals of Medicine and Surgery · 2024